相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存:
货期:电询
- 供应商:
MedChemExpress LLC
- CAS号:
299405-68-8
- 规格:
电询
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Antibacterial agent 143
CAS No. : 299405-68-8
MCE 国际站:Antibacterial agent 143
产品活性:Antibacterial agent 143 (Compound 5a) 是一种抗菌 (antibacterial) 剂,对 B. subtilis ATCC6633、S. aureus ATCC6538、P. aeruginosa ATCC13525 和 E. coli ATCC35218 的 MIC 值分别为 25、25、50 和 50 μg/mL。
研究领域:Anti-infection
作用靶点:Bacterial
相关产品:Rapamycin | Doxorubicin hydrochloride | Bafilomycin A1 | Dexamethasone | Puromycin dihydrochloride | Dimethyl sulfoxide | Staurosporine | Actinomycin D | G-418 disulfate | Etoposide | 5-Azacytidine | Nigericin sodium salt | Brefeldin A | Estradiol | CCCP | Ionomycin | Resveratrol | Hygromycin B | Tunicamycin | Mitomycin C | Everolimus | Doxycycline hyclate | Tacrolimus | Methotrexate | Neomycin sulfate | Acetaminophen | Streptozotocin | Anisomycin | Cholesterol
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Genomic Approaches to Antibacterial Discovery
of concept in curing experimental infections. The second approach is based on screening for compounds with antibacterial activity and then employing a broad variety of newer technologies to identify the molecular target of the antibacterial agent
Methods to Assay Inhibitors of tRNA Synthetase Activity
could be a potential antibacterial agent. Only one aa-RS inhibitor, the Ile-RS inhibitor mupirocin, is currently marketed as an antibacterial agent. We focused on phenylalanyl (Phe)-tRNA synthetase (Phe-RS), but the described methods are not restricted to Phe-RS
Assessing the Activity of Bacterial Multidrug Efflux Pumps
Resistance to antibiotics in target bacterial populations has long complicated antibacterial chemotherapy. First described in the early 1980s (1 , 2 ), efflux mechanism of resistance, whereby the antibiotic is actively (i.e., in an energy
技术资料暂无技术资料 索取技术资料

















